Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Par Pharmaceutical
Pharma
Jury awards $885M in Takeda pay-for-delay antitrust case
Takeda plans to appeal after a jury found it liable in a landmark pay-for-delay antitrust case and ordered the Japanese drugmaker to pay $885 million.
Kevin Dunleavy
May 19, 2026 8:39am
Par Pharma recalls blood pressure med for possible contamination
Apr 22, 2024 9:50am
Par recalls batch of Remodulin generic over particulate concerns
Mar 13, 2024 8:15am
Endo hits Zydus with patent suit over generic version of Chantix
Aug 11, 2023 10:45am
Merck, Glenmark must face jury trial in Zetia antitrust case
Feb 14, 2023 10:58am
Novartis pays $245M to settle Exforge generic pay-for-delay suit
Jan 3, 2023 11:22am
